🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10259+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10259 recruiting trials

Phase 3RecruitingNCT07062198

Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

👨‍⚕️ Sevki SAHIN, Prof. Dr., Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, University of Health Sciences Istanbul 34766, Turkiye📍 8 sites📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT06824701

Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

👨‍⚕️ Narendranath Epperla, MD, MS, FACP, Huntsman Cancer Institute/ University of Utah📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07205887

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

👨‍⚕️ Charles Miller, MD PhD, EyeBiotech Ltd.📍 49 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06161818

Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

👨‍⚕️ Bianca Mostert, MD, PhD, Erasmus Medical Centre📍 10 sites📅 Started Sep 2025View details ↗
Phase 3Enrolling by InvitationNCT06549400

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

🏥 Lupin Ltd.📍 6 sites📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT07177911

Safety and Efficacy Study of CC312 for Moderate to Severe SLE

🏥 CytoCares Inc📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07276087

Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls

🏥 ÖZLEM NUR TOK YAMAN📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07049848

SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma

👨‍⚕️ Ahsan S Farooqi, MD, PHD, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2025View details ↗
Phase 2, PHASE3RecruitingNCT07084662

Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma

🏥 Sun Yat-sen University📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07145801

Y-90 Treatment Response Using Transarterial Radioembolization

👨‍⚕️ John Eisenbrey, PhD, Thomas Jefferson University📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07013201

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

👨‍⚕️ Medical Expert, LEO Pharma📍 36 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07207408

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

🏥 Dynavax Technologies Corporation📍 3 sites📅 Started Sep 2025View details ↗
NARecruitingNCT07036445

Comparison of Interlaminar CT Guided Epidural Platelet Rich Plasma Versus Steroid Injection in Patients With Lumbar Radicular Pain

🏥 Clinique du Sport, Bordeaux Mérignac📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07459101

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4

🏥 Sunnybrook Health Sciences Centre📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07174726

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

👨‍⚕️ None None📍 6 sites📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT04789148

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

👨‍⚕️ Elizabeth A Lawson, MD, MMSc, Massachusetts General Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07272499

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

🏥 Ruijin Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT07029828

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 4 sites📅 Started Sep 2025View details ↗
NARecruitingNCT07110493

Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements

🏥 Skolkovo Institute of Science and Technology📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06599762

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

🏥 University of Manitoba📍 1 site📅 Started Sep 2025View details ↗
← PreviousPage 66 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →